Capital Impact Advisors, LLC Cerus Corp Transaction History

Capital Impact Advisors, LLC

  • $3.16 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023
BUY
$1.79 - $2.9 $15,195 - $24,618
8,489 Added 7.02%
129,404 $318,000
Q1 2023

May 23, 2023
BUY
$2.65 - $3.81 $21,414 - $30,788
8,081 Added 7.16%
120,915 $359,000
Q4 2022

Feb 14, 2023
BUY
$3.38 - $4.22 $338,000 - $422,000
100,000 Added 779.18%
112,834 $411,000
Q3 2022

Nov 21, 2022
BUY
$3.43 - $5.83 $44,020 - $74,822
12,834 New
12,834 $49,000

Others Institutions Holding CERS

# of Institutions
157
Shares Held
148M
Call Options Held
84.2K
Put Options Held
55.5K
View Full List

About CERUS CORP

CERS Quotes by TradingView
  • Ticker CERS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 177,090,000
  • Market Cap $321M
  • Description
  • Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...
More about CERS
Track This Portfolio

Track Capital Impact Advisors, LLC Portfolio

Follow Capital Impact Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Impact Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capital Impact Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email